Unlock Your
Potential With
Ketamine Therapy
for Depression

Achieve the depression breakthrough you’ve been waiting for. Impact’s psychedelic therapy uses clinician-prescribed ketamine for depression treatment, which often leads to rapid, meaningful results after your initial sessions.

See if you’re a candidate today.

Benefits of Impact Psychedelics for
Depression Treatment

01

Safe

Ketamine has been an FDA-approved anesthetic since 1970, is used safely as an off-label prescription for depression treatment, as well as anxiety, PTSD, OCD, and other diagnoses. It’s well tolerated and used with patients from young children to seniors.

Ketamine has been an FDA-approved anesthetic since 1970, is used safely as an off-label prescription for depression treatment, as well as anxiety, PTSD, OCD, and other diagnoses. It’s well tolerated and used with patients from young children to seniors.

Ketamine is the only clinician-prescribed psychedelic medicine. Impact’s licensed clinicians are highly qualified to prescribe and provide a therapeutic environment using ketamine as a treatment for depression and anxiety.

Over 85% of clients with depression or anxiety report improvement in symptoms after four sessions with Impact. Our therapeutic program helps produce rapid outcomes from beginning to end.

Impact’s ketamine therapy is fully virtual! Enjoy your therapeutic journey in comfort and safety, wherever you are, assisted by our expert psychedelic medicine guides and clinicians.

02

Legal

Ketamine is the only clinician-prescribed psychedelic medicine. Impact’s licensed clinicians are highly qualified to prescribe and provide a therapeutic environment using ketamine as a treatment for depression and anxiety.

03

Effective

Over 85% of clients with depression or anxiety report improvement in symptoms after four sessions with Impact. Our therapeutic program helps produce rapid outcomes from beginning to end.

04

Convenient

Impact’s ketamine therapy is fully virtual! Enjoy your therapeutic journey in comfort and safety, wherever you are, assisted by our expert psychedelic medicine guides and clinicians.

Please review the important safety information on our website for more information about the potential risks and side effects of ketamine

BENEFITS

Why Ketamine is Effective for Depression Treatment

It’s Rapidly Effective

Conventional antidepressants can take weeks to months to become effective. Ketamine’s benefits often begin to appear within hours, and clinical trials with ketamine have shown peak mood elevation about 24-36 hours after treatment, continuing to have a lasting effect throughout the week.

You Don’t Have to Take it Every Day

Unlike other psychiatric medications that are typically taken daily, ketamine treatments are far less frequent, which results in far fewer side effects. Our clients often begin with weekly administration during their initial program and then transition to less frequent sessions in subsequent programs.

Conventional antidepressants can take weeks to months to become effective. Ketamine’s benefits often begin to appear within hours, and clinical trials with ketamine have shown peak mood elevation about 24-36 hours after treatment, continuing to have a lasting effect throughout the week.

Unlike other psychiatric medications that are typically taken daily, ketamine treatments are far less frequent, which results in far fewer side effects. Our clients often begin with weekly administration during their initial program and then transition to less frequent sessions in subsequent programs.

One of the many benefits of the guided ketamine experience is to create a psychedelic, or “mind-revealing,” state of consciousness in order to facilitate lasting, meaningful personal growth and transformation.

The biological and neurochemical basis of ketamine creates an ideal state for making powerful, positive changes in your life. The actions and behaviors you take can be received more fully, and settle in more naturally, through the neuroplastic state ketamine induces.

It can promote awareness for new perspectives with enhanced neuroplasticity

One of the many benefits of the guided ketamine experience is to create a psychedelic, or “mind-revealing,” state of consciousness in order to facilitate lasting, meaningful personal growth and transformation.

The biological and neurochemical basis of ketamine creates an ideal state for making powerful, positive changes in your life. The actions and behaviors you take can be received more fully, and settle in more naturally, through the neuroplastic state ketamine induces.

REVIEWS

Hear from Our Clients

A RECENT EXPERIENCE

"I was really struggling with ruminating anxiety despite psychotherapy. My clinician Stephanie made me feel comfortable... and the experience blew my mind. I’m finally out of the rut I was in for several years. I LOVE that feeling."

Jonathan S. - healthcare provider in Phoenix, Arizona

We know that ketamine modulates additional receptor types, but the glutamate receptors seem to play the most important role in ketamine’s ability to treat depression and anxiety.

‍Neurons have a number of different binding sites for glutamate, but when it comes to ketamine, two are of particular interest: the NMDA receptor and the AMPA receptor.

‍By increasing the level of glutamate transmission while also shifting the balance of glutamate activation from NMDA to AMPA receptors, ketamine rapidly upregulates neuronal production and release of BDNF (brain-derived neurotrophic factor). Aptly called fertilizer for the brain, BDNF is a protein that helps promote the growth, maintenance, and survival of neurons—in other words, it enhances neuroplasticity.

The answer is often yes. Each person’s health profile is unique, and during your video consultation, a clinician will work with you to determine the best treatment plan based on your evaluation and health history. Some medications are contraindicated with ketamine, so please be sure to walk through your current medications with your clinician.

‍Some Impact clients have been able to safely taper off their anti-anxiety or antidepressant medications under the close supervision of their existing psychiatric providers, following improvements from ketamine therapy.

In addition to ketamine for anxiety, ketamine therapy is backed by research and used by Impact to treat depression. 

‍Ketamine has also been used successfully to treat post-traumatic stress disorder (PTSD), OCD, chronic pain, and is an emerging treatment for other diagnoses.

Ketamine therapy has an excellent safety record.

‍Impact Psychedelics’s clinical team and board of expert advisors have decades of experience in psychiatry, psychedelic research, and ketamine treatment. The clinical protocols that they’ve implemented ensure that we’re providing safe and science-backed treatment for all of our clients.

Our expert clinicians are licensed, and Impact Guides are equipped with experience and training to lead you safely through the entirety of your psychedelic therapy experience.

‍Impact has helped hundreds of clients achieve positive outcomes through ketamine therapy.

Using ketamine for depression treatment is 100% legal.

‍Currently, ketamine is the only legally prescribable psychedelic medicine available, and is available for off-label use for diagnoses like depression. Ketamine prescriptions are given exclusively through Impact Psychedelics’s licensed clinicians.

‍Learn more about the psychedelic medicine pipeline, and current clinical trials leading to advancements in the field of psychedelic therapy.

FAQ

We know that ketamine modulates additional receptor types, but the glutamate receptors seem to play the most important role in ketamine’s ability to treat depression and anxiety.

‍Neurons have a number of different binding sites for glutamate, but when it comes to ketamine, two are of particular interest: the NMDA receptor and the AMPA receptor.

‍By increasing the level of glutamate transmission while also shifting the balance of glutamate activation from NMDA to AMPA receptors, ketamine rapidly upregulates neuronal production and release of BDNF (brain-derived neurotrophic factor). Aptly called fertilizer for the brain, BDNF is a protein that helps promote the growth, maintenance, and survival of neurons—in other words, it enhances neuroplasticity.

The answer is often yes. Each person’s health profile is unique, and during your video consultation, a clinician will work with you to determine the best treatment plan based on your evaluation and health history. Some medications are contraindicated with ketamine, so please be sure to walk through your current medications with your clinician.

‍Some Impact clients have been able to safely taper off their anti-anxiety or antidepressant medications under the close supervision of their existing psychiatric providers, following improvements from ketamine therapy.

In addition to ketamine for anxiety, ketamine therapy is backed by research and used by Impact to treat depression. 

‍Ketamine has also been used successfully to treat post-traumatic stress disorder (PTSD), OCD, chronic pain, and is an emerging treatment for other diagnoses.

Ketamine therapy has an excellent safety record.

‍Impact Psychedelics’s clinical team and board of expert advisors have decades of experience in psychiatry, psychedelic research, and ketamine treatment. The clinical protocols that they’ve implemented ensure that we’re providing safe and science-backed treatment for all of our clients.

Our expert clinicians are licensed, and Impact Guides are equipped with experience and training to lead you safely through the entirety of your psychedelic therapy experience.

‍Impact has helped hundreds of clients achieve positive outcomes through ketamine therapy.

Using ketamine for depression treatment is 100% legal.

‍Currently, ketamine is the only legally prescribable psychedelic medicine available, and is available for off-label use for diagnoses like depression. Ketamine prescriptions are given exclusively through Impact Psychedelics’s licensed clinicians.

‍Learn more about the psychedelic medicine pipeline, and current clinical trials leading to advancements in the field of psychedelic therapy.